News

PASO Medical PASO Medical

Exciting Results For Prostate Cancer Patients

The ENZAMET Trial results were presented at the ASCO Annual Meeting (the world’s largest oncology conference). ENZAMET was one of 4 clinical trials chosen for presentation at the Plenary (Main) Session at the ASCO Conference on 3/6/19 (out of 3500 abstracts).

Read More
PASO Medical PASO Medical

PASO to conduct Odonate study of new anti-cancer drug

Peninsula & Southeast Haematology and Oncology Research Group have commenced the Odonate Therapeutics Inc research study of the new anti-cancer drug, tesetaxel, as a possible treatment for human epidermal growth factor receptor 2 (HER2) negative, hormone receptor (HR) positive breast cancer that is locally advanced or spread to one or more body parts.

Read More